» Articles » PMID: 33998219

[Research Progress of Endogenous Repair Strategy in Intervertebral Disc]

Overview
Specialty General Surgery
Date 2021 May 17
PMID 33998219
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To review the research progress of endogenous repair strategy (ERS) in intervertebral disc (IVD).

Methods: The domestic and foreign literature related to ERS in IVD in recent years was reviewed, and its characteristics, status, and prospect in the future were summarized.

Results: The key of ERS in IVD is to improve the vitality of stem/progenitor cells in IVD or promote its migration from stem cell Niche to the tissue that need to repair. These stem/progenitor cells in IVD are derived from nucleus pulposus, annulus fibrosus, and cartilaginous endplate, showing similar biological characteristics to mesenchymal stem cells including the expression of the specific stem/progenitor cell surface markers and gene, and also the capacity of multiple differentiations potential. However, the development, senescence, and degeneration of IVD have consumed these stem/progenitor cells, and the harsh internal microenvironment further impair their biological characteristics, which leads to the failure of endogenous repair in IVD. At present, relevant research mainly focuses on improving the biological characteristics of endogenous stem/progenitor cells, directly supplementing endogenous stem/progenitor cells, biomaterials and small molecule compounds to stimulate the endogenous repair in IVD, so as to improve the effect of endogenous repair.

Conclusion: At present, ERS has gotten some achievements in the treatment of IVD degeneration, but its related studies are still in the pre-clinical stage. So further studies regarding ERS should be carried out in the future, especially experiments and clinical transformation.

Citing Articles

Autologous cultured adipose derived mesenchymal stem cells combined with hyaluronic acid hydrogel in the treatment of discogenic low back pain: a study protocol for a phase II randomised controlled trial.

Zhang J, Sun T, Zhang W, Yang M, Li Z BMJ Open. 2022; 12(10):e063925.

PMID: 36283750 PMC: 9608519. DOI: 10.1136/bmjopen-2022-063925.

References
1.
Xu P, Guan J, Chen Y, Xiao H, Yang T, Sun H . Stiffness of photocrosslinkable gelatin hydrogel influences nucleus pulposus cell propertiesin vitro. J Cell Mol Med. 2020; 25(2):880-891. PMC: 7812302. DOI: 10.1111/jcmm.16141. View

2.
Liu Y, Li Y, Nan L, Wang F, Zhou S, Wang J . The effect of high glucose on the biological characteristics of nucleus pulposus-derived mesenchymal stem cells. Cell Biochem Funct. 2020; 38(2):130-140. DOI: 10.1002/cbf.3441. View

3.
. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

4.
Ciria M, Garcia N, Ontoria-Oviedo I, Gonzalez-King H, Carrero R, de la Pompa J . Mesenchymal Stem Cell Migration and Proliferation Are Mediated by Hypoxia-Inducible Factor-1α Upstream of Notch and SUMO Pathways. Stem Cells Dev. 2017; 26(13):973-985. PMC: 5510679. DOI: 10.1089/scd.2016.0331. View

5.
Ruddy R, Morshead C . Home sweet home: the neural stem cell niche throughout development and after injury. Cell Tissue Res. 2017; 371(1):125-141. DOI: 10.1007/s00441-017-2658-0. View